Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 21, Number 3—March 2015
Letter

Mycobacterium bovis BCG–Associated Osteomyelitis/Osteitis, Taiwan

Nan-Chang Chiu, Meng-Chin Lin, Wen-Li Lin, Shin-Yi Wang, Hsin Chi, Li-Min Huang, Ren-Bin Tang, Yhu-Chering Huang, Ching-Chuan Liu, Fu-Yuan Huang, and Tzou-Yien LinComments to Author 
Author affiliations: Mackay Memorial Hospital, Taipei, Taiwan (N.-C. Chiu, M.-C. Lin, W.-L. Lin, H. Chi, F.-Y. Huang); Mackay Junior College of Medicine, Nursing and Management, Taipei (N.-C. Chiu, H. Chi); Taiwan Centers for Disease Control, Taipei (S.-Y. Wang); National Taiwan University Hospital, Taipei (L.-M. Huang); Cheng Hsin General Hospital, Taipei (R.-B. Tang); Chang Gung Memorial Hospital, Taoyuan, Taiwan (Y.-C. Huang, T.-Y. Lin); National Cheng Kung University Hospital, Tainan, Taiwan (C.-C. Liu); Ministry of Health and Welfare, Executive Yuan, Taipei (T.-Y. Lin)

Main Article

Figure

Number of patient applications for compensation as a result of Mycobacterium bovis BCG osteomyelitis/osteitis to vaccine injury compensation program, Taiwan, 1998–2012.

Figure. Number of patient applications for compensation as a result of Mycobacterium bovis BCG osteomyelitis/osteitis to vaccine injury compensation program, Taiwan, 1998–2012.

Main Article

Page created: February 18, 2015
Page updated: February 18, 2015
Page reviewed: February 18, 2015
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external